Neelam Taneja

Dr. Neelam Taneja

Postgraduate Institute of Medical Education & Research, Chandigarh, Chandigarh, India
orcid
Professor & Head, Medical Microbiology, PGIMER | WHO BPPL Ad...

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Indian Journal of Medical Research
Verified
Journal Article
Open access
PDF file
Neelam TanejaNeelam Taneja
Neelam Taneja
MSMegha Sharma
Megha Sharma
Antimicrobial resistance (AMR) continues to pose a significant public health problem in terms of mortality and economic loss. Health authorities of several countries including India have formulated action plans for its containment. In this fight against AMR, it is important to realize the contribution by all the following four spheres: humans, animals, food and environment. This review incorporates all the spheres of One Health concept from the Indian perspective. India has one of the highest rates of resistance to antimicrobial agents used both in humans and food animals. The environment, especially the water bodies, have also reported the presence of resistant organisms or their genes. Specific socio-economic and cultural factors prevalent in India make the containment of resistance more challenging. Injudicious use of antimicrobials and inadequate treatment of waste waters are important drivers of AMR in India. Use of sludge in agriculture, improper discard of livestock animals and aquaculture industry are considered AMR contributors in other countries but Indian data regarding these are lacking. Efforts to combat AMR have been initiated by the Indian health authorities but are still at preliminary stages. Keeping in view the challenges unique to India, future directions are proposed.

MRMd Mahbubur Rahman
Md Mahbubur Rahman
MAMahbub-Ul Alam
Mahbub-Ul Alam
SLSharmin Khan Luies
Sharmin Khan Luies
AKabul kamal
abul kamal
SFSharika Ferdous
Sharika Ferdous
AEAyse Ercumen
Ayse Ercumen
Fresh produce, when consumed raw, can be a source of exposure to antimicrobial residues, antimicrobial-resistant bacteria (ARB) and antimicrobial resistance genes (ARGs) of clinical importance. This review aims to determine: (1) the presence and abundance of antimicrobial residues, ARB and ARGs in fresh agricultural products sold in retail markets and consumed raw; (2) associated health risks in humans; and (3) pathways through which fresh produce becomes contaminated with ARB/ARGs. We searched the Ovid Medline, Web of Science and Hinari databases as well as grey literature, and identified 40 articles for inclusion. All studies investigated the occurrence of multidrug-resistant bacteria, and ten studies focused on ARGs in fresh produce, while none investigated antimicrobial residues. The most commonly observed ARB were E. coli (42.5%) followed by Klebsiella spp. (22.5%), and Salmonella spp. (20%), mainly detected on lettuce. Twenty-five articles mentioned health risks from consuming fresh produce but none quantified the risk. About half of the articles stated produce contamination occurred during pre- and post-harvest processes. Our review indicates that good agricultural and manufacturing practices, behavioural change communication and awareness-raising programs are required for all stakeholders along the food production and consumption supply chain to prevent ARB/ARG exposure through produce.

1 May 2016 in Indian Journal of Medical Research
Verified
Journal Article
Open access
PDF file
Neelam TanejaNeelam Taneja
Neelam Taneja
AMAbhishek Mewara
Abhishek Mewara
Shigellosis is one of the major causes of diarrhoea in India. The accurate estimates of morbidity and mortality due to shigellosis are lacking, though it is endemic in the country and has been reported to cause many outbreaks. The limited information available indicates Shigella to be an important food-borne pathogen in India. S. flexneri is the most common species, S. sonnei and non-agglutinable shigellae seem to be steadily surfacing, while S. dysenteriae has temporarily disappeared from the northern and eastern regions. Antibiotic-resistant strains of different Shigella species and serotypes have emerged all over the world. Especially important is the global emergence of multidrug resistant shigellae, notably the increasing resistance to third generation cephalosporins and fluoroquinolones, and also azithromycin. This calls for a continuous and strong surveillance of antibiotic resistance across the country for periodic updation of the local antibiograms. The prevention of shigellosis is desirable as it will substantially reduce the morbidity associated with diarrhoea in the country. Public health measures like provision of safe water and adequate sanitation are of immense importance to reduce the burden of shigellosis, however, the provision of resources to develop such an infrastructure in India is a complex issue and will take time to resolve. Thus, the scientific thrust should be focused towards development of a safe and affordable multivalent vaccine. This review is focused upon the epidemiology, disease burden and the therapeutic challenges of shigellosis in Indian perspective.

12 March 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
Neelam TanejaNeelam Taneja
Neelam Taneja
AMAbhishek Mewara
Abhishek Mewara
AKAjay Kumar
Ajay Kumar
GVGarima Verma
Garima Verma
MSMeera Sharma
Meera Sharma
To determine the pattern and antimicrobial resistance genes of cephalosporin resistance in Shigella flexneri and Shigella dysenteriae over 9 years. Isolates of Shigella (S. flexneri, n = 119 and S. dysenteriae, n = 24) were tested for resistance to ceftriaxone and cefepime by disc diffusion, for MIC by Etest and for extended-spectrum β-lactamase (ESBL) and AmpC production. The presence of antimicrobial resistance genes was investigated by PCR using specific primers for blaTEM, blaOXA-1, blaCTX-M-15, blaSHV and blaCMY-2 for all the isolates. Twenty (16.8%) S. flexneri isolates were resistant/intermediately susceptible to ceftriaxone/cefepime, while all S. dysenteriae were susceptible. In S. flexneri isolates, the MIC50 values of ceftriaxone and cefepime were found to be 0.032 and 0.125 mg/L, respectively, while their MIC90 values were 12 and 8 mg/L, respectively. The MIC50 and MIC90 for S. dysenteriae were below 1 mg/L for ceftriaxone; however, for cefepime the MIC90 was found to be 4 mg/L. Of the 20 resistant/intermediately susceptible S. flexneri isolates, 9 were positive for ESBL production and 4 for AmpC production by phenotypic tests. All 20 isolates were found to be positive for blaTEM, 10 for blaCTX-M-15, 8 for blaOXA and 7 for blaCMY-2; none was positive for blaSHV. We report a high level of cephalosporin resistance with high MICs and ESBL- and AmpC-mediated antibiotic resistance in Shigella from north India.

1 February 2007 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
Neelam TanejaNeelam Taneja
Neelam Taneja

1 November 2004 in Burns
Verified
Journal Article
Closed access
Neelam TanejaNeelam Taneja
Neelam Taneja
RERekha Emmanuel
Rekha Emmanuel
PCP.S. Chari
P.S. Chari
MSMeera Sharma
Meera Sharma